Please note that any information that you supply is protected by our Privacy and Cookies Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
|
Medical researchers are arming themselves with a new series of weapons in the war against disease - conjugated drugs that link biological molecules to a highly potent active pharmaceutical ingredient (HPAPIs). Only a handful of companies have the combination of experience in biologics, conjugation technology, HPAPI production and containment requirements to commercialize biologic-HPAPI conjugates. SAFC Pharma discusses what is needed to be an effective development partner in this complex area.